Working with
patients in mind
Self Reflected by Greg Dunn
Our
Mission

We are dedicated to helping people suffering from neuropsychiatric disorders by transforming psychedelics into effective and licensed medicines.

Our
Research

Beckley Psytech’s innovative approach to helping patients in need is focused on developing novel psychedelic therapies to improve patient outcomes.

More about our work

Compounds

Progressing innovative formulations and applications of psychedelic agents such as 5-MeO-DMT, psilocin and other compounds

Psychological Support

Leveraging personalised psychological support to target clinically meaningful improvements in a less time and resource intensive way

Digital

Designing digital tools that deliver a holistic and differentiated solution to optimise patient outcomes

Lady Amanda Feilding
Our
Story

For our founders, Lady Amanda Feilding and Cosmo Feilding Mellen, psychedelic medicines have been a lifelong and intergenerational vocation.

More about us
Our
Leadership
Team
Cosmo Feilding Mellen
CEO
Dr. Rob Conley
Chief Scientific and Medical Officer
Dr. Fiona Dunbar
Chief Medical Advisor
Becky Verity
Chief Commercial Officer
Michael Norris
Chief Financial Officer
Shlomi Raz
Chief Business Officer
Matt Hartley
Chief Operating Officer
Tim Mason
Chief Development Officer
News
and
views
Read all news